ArticleTranslational cancer research2026
Efficacy and safety of antibody-drug conjugates for HR+/HER2-low advanced breast cancer: a systematic review with Bayesian network meta-analysis and real-world study.
Linbing Duan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.